Mesodiencephalic modulation in complex therapy of diabetic polyneuropathy

Abstract

The effect of mesodiencephalic modulation on the metabolism of carbohydrates and lipids, insulin and cortisol secretion, the severity of neurological disorders and pain syndrome has been studied in patients with diabetic polyneuropathy. It has been established that the addition of a standard therapeutic complex with MDM-therapy reduces the neurological symptoms of the disease and the severity of the pain syndrome by half, as well as significantly improves the insulin regulation of carbohydrate and lipid metabolism. It has been proven that MDM-therapy reduces the body’s insulin resistance, which makes it possible to recommend this physical factor for the treatment of diseases associated with metabolic syndrome. The hypothesis of the systemic nature of MDM-therapy and its effect on the formation of adaptive responses is considered.